Display options
Cite
Scicchitano F, Giofrè C, Palleria C, et al. Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci. 2012;17(9):872-5
Scicchitano, F., Giofrè, C., Palleria, C., Mazzitello, C., Ciriaco, M., Gallelli, L., Paletta, L., Marrazzo, G., De Fazio, S., Menniti, M., Curia, R., Arena, C., Chimirri, S., Patanè, M., Esposito, S., Cilurzo, F., Staltari, O., Russo, E., & De Sarro, G. (2012). Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 17(9), 872-5.
Scicchitano, Francesca, et al. "Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 17,9 (2012): 872-5.
Scicchitano F, Giofrè C, Palleria C, Mazzitello C, Ciriaco M, Gallelli L, Paletta L, Marrazzo G, De Fazio S, Menniti M, Curia R, Arena C, Chimirri S, Patanè M, Esposito S, Cilurzo F, Staltari O, Russo E, De Sarro G. Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci. 2012 Sep;17(9):872-5. PMID: 23826016; PMCID: PMC3697214.
Copy Download .nbib Format: NLM
Share it on

J Res Med Sci. 2012 Sep;17(9):872-5.

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Francesca Scicchitano, Chiara Giofrè, Caterina Palleria, Carmela Mazzitello, Miriam Ciriaco, Luca Gallelli, Laura Paletta, Giuseppina Marrazzo, Salvatore De Fazio, Michele Menniti, Rubens Curia, Concetta Arena, Serafina Chimirri, Marinella Patanè, Stefania Esposito, Felisa Cilurzo, Orietta Staltari, Emilio Russo, Giovambattista De Sarro

Affiliations

  1. Department of Science of Health, School of Medicine, University of Catanzaro, Italy and Pharmacovigilance's Centre Calabria Region, University Hospital Mater Domini, Catanzaro, Italy.

PMID: 23826016 PMCID: PMC3697214

Abstract

BACKGROUND: Pharmacovigilance assesses the safety profile of drugs. Its main aim is the increase of spontaneous reporting of adverse drug reactions (ADRs). The Italian Drug Agency (AIFA; Agenzia Italiana del Farmaco) is financing several projects to the aim of increasing reporting, and in Calabria a Pharmacovigilance Information Centre has been created.

MATERIALS AND METHODS: We analyzed the AIFA database relatively to Calabria in the year 2011 and we have analyzed ADRs using descriptive statistics. We have also collected a questionnaire-based interview in order to describe the background knowledge in the field.

RESULTS: Regarding the number of AIFA reported ADRs from Calabria, a 38% increase (138 vs. 100) in comparison to 2010 was evidenced. Hospital Doctors represent the main source of signaling (71.7 %). Ketoprofene and the combination amoxicillin/clavulanic acid represent the most frequently reported drugs causing ADRs. Our questionnaires indicated that despite the health professionals have met at least once an ADR only a small percentage of them was reported to the authorities (37%). There is a very good knowledge of the ADR concept and reporting system (90% of interviewed distinguish an ADR and knows how to report it), and there is a strong interest in participating to training courses in the field (95% are interested).

CONCLUSIONS: Despite Calabria has had a positive increase in the number of reported ADRs, the total number is very low and the pharmacovigilance culture is far from being achieved in this region.

Keywords: Adverse drug reaction reporting systems; adverse effects; calabria; drug toxicity; italy; pharmacovigilance

References

  1. Ital J Pediatr. 2010 Jan 15;36:4 - PubMed
  2. J Res Med Sci. 2011 Jan;16(1):16-25 - PubMed
  3. Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):217-22 - PubMed
  4. Perspect Clin Res. 2011 Oct;2(4):129-36 - PubMed
  5. BMJ Open. 2012 Mar 15;2(2):e000642 - PubMed
  6. Drug Saf. 2009;32(1):19-31 - PubMed
  7. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):597-602 - PubMed
  8. J Young Pharm. 2010 Jul;2(3):315-20 - PubMed
  9. Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1237-45 - PubMed
  10. J Patient Saf. 2009 Mar;5(1):16-22 - PubMed

Publication Types